A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network.
Saved in:
| Title: | A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network. |
|---|---|
| Authors: | Mross K (AUTHOR), Dittrich C (AUTHOR), Aulitzky WE (AUTHOR), Strumberg D (AUTHOR), Schutte J (AUTHOR), Schmid RM (AUTHOR), Hollerbach S (AUTHOR), Merger M (AUTHOR), Munzert G (AUTHOR), Fleischer F (AUTHOR), Scheulen ME (AUTHOR), Mross, K1 (AUTHOR), Dittrich, C (AUTHOR), Aulitzky, W E (AUTHOR), Strumberg, D (AUTHOR), Schutte, J (AUTHOR), Schmid, R M (AUTHOR), Hollerbach, S (AUTHOR), Merger, M (AUTHOR), Munzert, G (AUTHOR) |
| Source: | British Journal of Cancer. 7/10/2012, Vol. 107 Issue 2, p280-286. 7p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 104382797 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mross+K%22">Mross K</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dittrich+C%22">Dittrich C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aulitzky+WE%22">Aulitzky WE</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Strumberg+D%22">Strumberg D</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schutte+J%22">Schutte J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmid+RM%22">Schmid RM</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hollerbach+S%22">Hollerbach S</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Merger+M%22">Merger M</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Munzert+G%22">Munzert G</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fleischer+F%22">Fleischer F</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scheulen+ME%22">Scheulen ME</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mross%2C+K%22">Mross, K</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dittrich%2C+C%22">Dittrich, C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aulitzky%2C+W+E%22">Aulitzky, W E</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Strumberg%2C+D%22">Strumberg, D</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schutte%2C+J%22">Schutte, J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmid%2C+R+M%22">Schmid, R M</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hollerbach%2C+S%22">Hollerbach, S</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Merger%2C+M%22">Merger, M</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Munzert%2C+G%22">Munzert, G</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Cancer%22">British Journal of Cancer</searchLink>. 7/10/2012, Vol. 107 Issue 2, p280-286. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=104382797 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/bjc.2012.257 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 280 Titles: – TitleFull: A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mross K – PersonEntity: Name: NameFull: Dittrich C – PersonEntity: Name: NameFull: Aulitzky WE – PersonEntity: Name: NameFull: Strumberg D – PersonEntity: Name: NameFull: Schutte J – PersonEntity: Name: NameFull: Schmid RM – PersonEntity: Name: NameFull: Hollerbach S – PersonEntity: Name: NameFull: Merger M – PersonEntity: Name: NameFull: Munzert G – PersonEntity: Name: NameFull: Fleischer F – PersonEntity: Name: NameFull: Scheulen ME – PersonEntity: Name: NameFull: Mross, K – PersonEntity: Name: NameFull: Dittrich, C – PersonEntity: Name: NameFull: Aulitzky, W E – PersonEntity: Name: NameFull: Strumberg, D – PersonEntity: Name: NameFull: Schutte, J – PersonEntity: Name: NameFull: Schmid, R M – PersonEntity: Name: NameFull: Hollerbach, S – PersonEntity: Name: NameFull: Merger, M – PersonEntity: Name: NameFull: Munzert, G IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 07 Text: 7/10/2012 Type: published Y: 2012 Identifiers: – Type: issn-print Value: 00070920 Numbering: – Type: volume Value: 107 – Type: issue Value: 2 Titles: – TitleFull: British Journal of Cancer Type: main |
| ResultId | 1 |
